Capital Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Capital Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.4M	Sell	204,573 -3,461	-2%	-$202K	0.18%	103
2025 Q4	$11.2M	Sell	208,034 -6,293	-3%	-$303K	0.17%	110
2025 Q3	$9.67M	Sell	214,327 -2,123	-1%	-$99.1K	0.16%	112
2025 Q2	$10M	Sell	216,450 -13,281	-6%	-$652K	0.18%	108
2025 Q1	$14M	Sell	229,731 -18,061	-7%	-$1.05M	0.27%	84
2024 Q4	$14M	Sell	247,792 -11,722	-5%	-$655K	0.29%	81
2024 Q3	$13.4M	Sell	259,514 -1,226	-0.5%	-$57.5K	0.28%	81
2024 Q2	$10.8M	Sell	260,740 -12,737	-5%	-$570K	0.24%	88
2024 Q1	$14.8M	Buy	273,477 +9,721	+4%	+$495K	0.35%	76
2023 Q4	$13.5M	Sell	263,756 -18,090	-6%	-$950K	0.34%	72
2023 Q3	$16.4M	Buy	281,846 +7,629	+3%	+$467K	0.45%	62
2023 Q2	$17.5M	Buy	274,217 +4,695	+2%	+$315K	0.53%	49
2023 Q1	$18.7M	Buy	269,522 +9,554	+4%	+$674K	0.55%	52
2022 Q4	$18.7M	Buy	259,968 +13,996	+6%	+$1.06M	0.57%	49
2022 Q3	$17.5M	Buy	245,972 +12,286	+5%	+$891K	0.6%	45
2022 Q2	$18M	Buy	233,686 +9,151	+4%	+$697K	0.6%	43
2022 Q1	$16.4M	Buy	224,535 +8,596	+4%	+$577K	0.5%	50
2021 Q4	$13.5M	Buy	215,939 +6,660	+3%	+$391K	0.41%	58
2021 Q3	$12.4M	Buy	209,279 +24,507	+13%	+$1.61M	0.42%	58
2021 Q2	$12.3M	Buy	184,772 +13,899	+8%	+$906K	0.43%	56
2021 Q1	$10.8M	Buy	170,873 +24,426	+17%	+$1.52M	0.41%	57
2020 Q4	$9.08M	Buy	146,447 +30,136	+26%	+$1.85M	0.38%	60
2020 Q3	$7.01M	Buy	116,311 +7,055	+6%	+$425K	0.33%	66
2020 Q2	$6.42M	Buy	109,256 +12,628	+13%	+$755K	0.33%	69
2020 Q1	$5.39M	Buy	96,628 +1,140	+1%	+$69.7K	0.34%	67
2019 Q4	$6.13M	Sell	95,488 -1,897	-2%	-$109K	0.3%	85
2019 Q3	$4.94M	Buy	97,385 +6,956	+8%	+$327K	0.26%	95
2019 Q2	$4.1M	Buy	90,429 +22,015	+32%	+$1.03M	0.22%	101
2019 Q1	$3.26M	Buy	68,414 +13,635	+25%	+$679K	0.19%	104
2018 Q4	$2.85M	Buy	54,779 +10,090	+23%	+$542K	0.19%	106
2018 Q3	$2.77M	Sell	44,689 -317	-0.7%	-$18.8K	0.16%	111
2018 Q2	$2.49M	Buy	45,006 +476	+1%	+$25.7K	0.16%	118
2018 Q1	$2.82M	Sell	44,530 -621	-1%	-$39.9K	0.18%	112
2017 Q4	$2.77M	Sell	45,151 -504	-1%	-$31.5K	0.18%	115
2017 Q3	$2.91M	Sell	45,655 -678	-1%	-$39.6K	0.2%	111
2017 Q2	$2.58M	Buy	46,333 +3,500	+8%	+$190K	0.19%	118
2017 Q1	$2.33M	Buy	42,833 +63	+0.1%	+$3.46K	0.18%	117
2016 Q4	$2.5M	Buy	42,770 +1,410	+3%	+$77.1K	0.21%	107
2016 Q3	$2.23M	Buy	41,360 +312	+0.8%	+$20K	0.2%	113
2016 Q2	$3.02M	Sell	41,048 -815	-2%	-$57.6K	0.28%	80
2016 Q1	$2.67M	Sell	41,863 -585	-1%	-$36.9K	0.26%	82
2015 Q4	$2.92M	Buy	42,448 +3,356	+9%	+$222K	0.3%	72
2015 Q3	$2.31M	Sell	39,092 -741	-2%	-$47K	0.26%	84
2015 Q2	$2.65M	Sell	39,833 -1,439	-3%	-$94.8K	0.29%	82
2015 Q1	$2.66M	Sell	41,272 -415	-1%	-$26K	0.28%	82
2014 Q4	$2.46M	Sell	41,687 -631	-1%	-$35.6K	0.27%	86
2014 Q3	$2.17M	Buy	42,318 +263	+0.6%	+$13.1K	0.25%	94
2014 Q2	$2.04M	Sell	42,055 -2,047	-5%	-$101K	0.23%	104
2014 Q1	$2.29M	Sell	44,102 -729	-2%	-$38.8K	0.29%	89
2013 Q4	$2.38M	Buy	+44,831	New	+$2.28M	0.32%	81

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Investment Advisors's BMY Position: Q1 2026 in Review

Capital Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q1 2026, selling an estimated $202K and leaving 204,573 shares worth $12.4M. The position accounts for 0.18% of the portfolio, ranked #103.

Capital Investment Advisors first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $18.7M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Capital Investment Advisors held 204,573 shares of Bristol-Myers Squibb worth $12.4M as of Q1 2026.
Capital Investment Advisors sold 3,461 Bristol-Myers Squibb shares in Q1 2026, an estimated $202K.
Bristol-Myers Squibb made up 0.18% of Capital Investment Advisors's portfolio in Q1 2026, its #103 holding.
Capital Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
Capital Investment Advisors's Bristol-Myers Squibb position peaked at $18.7M in Q4 2022.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.